Novo Nordisk

Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. Founded in 1923, it specializes in treatments for diabetes, obesity, hemophilia, and other chronic conditions. The company is a global leader in insulin production and develops drugs such as semaglutide. It operates in over 80 countries and is one of Europe's most valuable corporations by market capitalization.

Novo Nordisk, Inc. reported a data breach to the Massachusetts Office of Consumer Affairs and Business Regulation. The breach was reported on 2020-02-10. 6 Massachusetts residents were affected. The report records the breach type as electronic.

Novo Nordisk Inc. reported a data breach affecting 2 New Hampshire employees. Payroll vendor ADP inadvertently exposed email addresses and SSNs to an HR professional at another ADP client on Oct 15, 2014. Novo Nordisk detected the incident on Nov 13, 2014, and notified affected individuals on Dec 1, 2014. No law enforcement investigation was requested.

Novo Nordisk Inc. notified the NH Attorney General of a data breach affecting 2 NH residents. A vendor accidentally disclosed a report containing employee email addresses and SSNs to a third party. The vendor contacted the recipient, who destroyed the copies. NNI is notifying affected employees and offering credit monitoring.